News on Intercell AG from BioPortfolio.com http://www.BioPortfolio.com Consolidated Intercell AG news from BioPortfolio.com Wed, 10 Feb 2010 15:41:05 GMT en Novartis Negotiates Rights to Debiopharms Mid-Stage HCV Candidatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039713&HITNO=0&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039713&THISHREF=http://c.moreover.com/click/here.pl%3fz2538336802%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039713&HITNO=0&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039713&THISHREF=http://c.moreover.com/click/here.pl%3fz2538336802%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Four-day 'BioAsia 2010' to be held in Hyderabad from Feb 3http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952849&HITNO=1&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952849&THISHREF=http://c.moreover.com/click/here.pl%3fz2491034954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952849&HITNO=1&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952849&THISHREF=http://c.moreover.com/click/here.pl%3fz2491034954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: BioAsia 2010 Begins in Hyderabad from February 3http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950820&HITNO=2&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950820&THISHREF=http://c.moreover.com/click/here.pl%3fz2489842997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950820&HITNO=2&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950820&THISHREF=http://c.moreover.com/click/here.pl%3fz2489842997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: RCB upgrades Austrian Intercell to 'buy'http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939731&HITNO=3&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939731&THISHREF=http://c.moreover.com/click/here.pl%3fz2484751241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939731&HITNO=3&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939731&THISHREF=http://c.moreover.com/click/here.pl%3fz2484751241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comADP News: STOCKS NEWS EUROPE-Intercell rises on Glaxo bid talkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923298&HITNO=4&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923298&THISHREF=http://c.moreover.com/click/here.pl%3fz2476453259%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923298&HITNO=4&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923298&THISHREF=http://c.moreover.com/click/here.pl%3fz2476453259%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters India: STOCKS NEWS EUROPE-Intercell rises on Glaxo bid talkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923173&HITNO=5&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923173&THISHREF=http://c.moreover.com/click/here.pl%3fz2476384913%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923173&HITNO=5&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923173&THISHREF=http://c.moreover.com/click/here.pl%3fz2476384913%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters UK: Biological E inks pact with VaxInnate of US to license its recombinant H1N1 pandemic vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912332&HITNO=6&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912332&THISHREF=http://c.moreover.com/click/here.pl%3fz2470155982%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912332&HITNO=6&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912332&THISHREF=http://c.moreover.com/click/here.pl%3fz2470155982%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Sal. Oppenheim ups Intercell's fair value estimatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904406&HITNO=7&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904406&THISHREF=http://c.moreover.com/click/here.pl%3fz2465658625%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904406&HITNO=7&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904406&THISHREF=http://c.moreover.com/click/here.pl%3fz2465658625%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comADP News: GSK Gets under Your Skinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888128&HITNO=8&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888128&THISHREF=http://c.moreover.com/click/here.pl%3fz2458312213%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888128&HITNO=8&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888128&THISHREF=http://c.moreover.com/click/here.pl%3fz2458312213%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Intercell starts an additional efficacy trial for its patch-based investigational Travelers ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861884&HITNO=9&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861884&THISHREF=http://c.moreover.com/click/here.pl%3fz2444676365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861884&HITNO=9&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861884&THISHREF=http://c.moreover.com/click/here.pl%3fz2444676365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Intercell starts an additional efficacy trial for its patch-based investigational Travelers ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861883&HITNO=10&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861883&THISHREF=http://c.moreover.com/click/here.pl%3fz2444676159%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861883&HITNO=10&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861883&THISHREF=http://c.moreover.com/click/here.pl%3fz2444676159%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Intercell starts an additional efficacy trial for its patch-based investigational Travelers' Diarrhea Vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3864075&HITNO=11&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3864075&THISHREF=http://c.moreover.com/click/here.pl%3fz2445853094%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3864075&HITNO=11&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3864075&THISHREF=http://c.moreover.com/click/here.pl%3fz2445853094%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: Intercell starts an additional efficacy trial for its patch-based investigational Travelers Diarrhea Vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861550&HITNO=12&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861550&THISHREF=http://c.moreover.com/click/here.pl%3fz2444505809%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861550&HITNO=12&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861550&THISHREF=http://c.moreover.com/click/here.pl%3fz2444505809%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: Sal. Oppenheim keeps 'buy' on Austrian Intercellhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3859528&HITNO=13&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3859528&THISHREF=http://c.moreover.com/click/here.pl%3fz2443669597%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3859528&HITNO=13&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3859528&THISHREF=http://c.moreover.com/click/here.pl%3fz2443669597%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comADP News: Intercell announces initiation in the U.S. of a Phase III study for vaccine to protect children against Japanehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861542&HITNO=14&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861542&THISHREF=http://c.moreover.com/click/here.pl%3fz2444504635%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861542&HITNO=14&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Intercell%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861542&THISHREF=http://c.moreover.com/click/here.pl%3fz2444504635%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: